Youngbin Cho, Matthew S Laird, Teddi Bishop, Ruxuan Li, Dorota E Jazwinska, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis
{"title":"CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays.","authors":"Youngbin Cho, Matthew S Laird, Teddi Bishop, Ruxuan Li, Dorota E Jazwinska, Elisa Ruffo, Jason Lohmueller, Ioannis K Zervantonakis","doi":"10.1063/5.0207941","DOIUrl":null,"url":null,"abstract":"<p><p>The success of chimeric antigen receptor (CAR) T cells in blood cancers has intensified efforts to develop CAR T therapies for solid cancers. In the solid tumor microenvironment, CAR T cell trafficking and suppression of cytotoxic killing represent limiting factors for therapeutic efficacy. Here, we present a microwell platform to study CAR T cell interactions with 3D breast tumor spheroids and determine predictors of anti-tumor CAR T cell function. To precisely control antigen sensing, we utilized a switchable adaptor CAR system that covalently attaches to co-administered antibody adaptors and mediates antigen recognition. Following the addition of an anti-HER2 adaptor antibody, primary human CAR T cells exhibited higher infiltration, clustering, and secretion of effector cytokines. By tracking CAR T cell killing in individual spheroids, we showed the suppressive effects of spheroid size and identified the initial CAR T cell to spheroid area ratio as a predictor of cytotoxicity. We demonstrate that larger spheroids exhibit higher hypoxia levels and are infiltrated by CAR T cells with a suppressed activation state, characterized by reduced expression of IFN-γ, TNF-α, and granzyme B. Spatiotemporal analysis revealed lower CAR T cell numbers and cytotoxicity in the spheroid core compared to the periphery. Finally, increasing CAR T cell seeding density resulted in higher CAR T cell infiltration and cancer cell elimination in the spheroid core. Our findings provide new quantitative insight into CAR T cell function within 3D cancer spheroids. Given its miniaturized nature and live imaging capabilities, our microfabricated system holds promise for screening cellular immunotherapies.</p>","PeriodicalId":46288,"journal":{"name":"APL Bioengineering","volume":"8 3","pages":"036105"},"PeriodicalIF":6.6000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268919/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"APL Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1063/5.0207941","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The success of chimeric antigen receptor (CAR) T cells in blood cancers has intensified efforts to develop CAR T therapies for solid cancers. In the solid tumor microenvironment, CAR T cell trafficking and suppression of cytotoxic killing represent limiting factors for therapeutic efficacy. Here, we present a microwell platform to study CAR T cell interactions with 3D breast tumor spheroids and determine predictors of anti-tumor CAR T cell function. To precisely control antigen sensing, we utilized a switchable adaptor CAR system that covalently attaches to co-administered antibody adaptors and mediates antigen recognition. Following the addition of an anti-HER2 adaptor antibody, primary human CAR T cells exhibited higher infiltration, clustering, and secretion of effector cytokines. By tracking CAR T cell killing in individual spheroids, we showed the suppressive effects of spheroid size and identified the initial CAR T cell to spheroid area ratio as a predictor of cytotoxicity. We demonstrate that larger spheroids exhibit higher hypoxia levels and are infiltrated by CAR T cells with a suppressed activation state, characterized by reduced expression of IFN-γ, TNF-α, and granzyme B. Spatiotemporal analysis revealed lower CAR T cell numbers and cytotoxicity in the spheroid core compared to the periphery. Finally, increasing CAR T cell seeding density resulted in higher CAR T cell infiltration and cancer cell elimination in the spheroid core. Our findings provide new quantitative insight into CAR T cell function within 3D cancer spheroids. Given its miniaturized nature and live imaging capabilities, our microfabricated system holds promise for screening cellular immunotherapies.
嵌合抗原受体(CAR)T 细胞在治疗血癌方面的成功,加大了开发 CAR T 疗法治疗实体瘤的力度。在实体瘤微环境中,CAR T 细胞的迁移和细胞毒性杀伤抑制是限制疗效的因素。在这里,我们提出了一种微孔平台,用于研究 CAR T 细胞与三维乳腺肿瘤球体的相互作用,并确定 CAR T 细胞抗肿瘤功能的预测因素。为了精确控制抗原感应,我们利用了一种可切换的适配器 CAR 系统,它能共价连接到共给的抗体适配器上并介导抗原识别。加入抗 HER2 适配抗体后,原代人类 CAR T 细胞表现出更高的浸润、集群和效应细胞因子分泌。通过跟踪单个球体内 CAR T 细胞的杀伤情况,我们发现了球体大小的抑制作用,并确定了初始 CAR T 细胞与球体面积的比率是细胞毒性的预测因子。时空分析表明,与外围相比,球核中的 CAR T 细胞数量和细胞毒性较低。最后,CAR T细胞播种密度的增加导致球核中CAR T细胞浸润和癌细胞清除率的增加。我们的研究结果为了解 CAR T 细胞在三维癌症球体内的功能提供了新的定量视角。鉴于其微型化特性和活体成像能力,我们的微加工系统有望用于筛选细胞免疫疗法。
期刊介绍:
APL Bioengineering is devoted to research at the intersection of biology, physics, and engineering. The journal publishes high-impact manuscripts specific to the understanding and advancement of physics and engineering of biological systems. APL Bioengineering is the new home for the bioengineering and biomedical research communities.
APL Bioengineering publishes original research articles, reviews, and perspectives. Topical coverage includes:
-Biofabrication and Bioprinting
-Biomedical Materials, Sensors, and Imaging
-Engineered Living Systems
-Cell and Tissue Engineering
-Regenerative Medicine
-Molecular, Cell, and Tissue Biomechanics
-Systems Biology and Computational Biology